Open AccessA First-in-Man Clinical Evaluation of Sirolimus and Ascorbic Acid-Eluting Stent Systems: a Multicenter, Subject-Blinded, Randomized Study
Author(s) -
YoungHyo Lim,
Ji Hyun Youn,
Soon Jun Hong,
Tae Hoon Ahn,
Jung Han Yoon,
Jun Kyu Park,
Hyo Soo Kim
Publication year - 2021
Publication title -
korean circulation journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.809
H-Index - 29
eISSN - 1738-5555
pISSN - 1738-5520
DOI - 10.4070/kcj.2021.0161
Subject(s) - medicine , myocardial infarction , unstable angina , stent , clinical endpoint , target lesion , drug eluting stent , cardiology , stenosis , surgery , adverse effect , randomized controlled trial , restenosis , percutaneous coronary intervention
This clinical trial was conducted to evaluate the safety and efficacy of D+Storm™ drug-eluting stent (DES) and BioMatrix Flex™ DES.